Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amyris Making Headway In Fermentation-Derived Cannabinoids; CBD Could Hit Market In Early 2020

Dec 31 2019

• By Ryan Nelson

Medical engineering concept_227959225_1200.jpg

Related Content

Biossance Doubles Down On 'Free Of' Marketing With Ingredient Blacklist

May 12 2016

P&G Teams With Firm To Turn Microbes Into Functional Ingredient "Factories"

Jul 05 2010

CBD Suits Challenge ‘THC-Free’ Claims After Users Fail Drug Tests; Plaintiffs Bar May Just Be Warming Up

Aug 22 2019

Related Companies

Procter & Gamble

Additional Topics

Business Strategies Cosmetics Ingredients Innovation Consumer

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window